Eli Lillys daily anti-obesity pill orforglipron appears to be as good at spurring weight loss and lowering blood sugar in diabetes patients as popular injectable GLP-1 drugs like Ozempic, according t… [+3618 chars]...
Read moreWhen Chris Spears' pharmacy didn't have the obesity drug his doctor prescribed in 2023, he found another option while scrolling on Facebook. His feed was full of advertisements for alternatives to th… [+12842 chars]...
Read moreNovo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous … [+6478 chars]...
Read moreToday The Atlantic is announcing the first slate of speakers who will take part in The Atlantic Festival, its flagship event. Tickets will go on sale starting Thursday. The festival is making its New… [+2364 chars]...
Read moreJohn Mulcahy, SiteOne Therapeutics CEOLilly to buy non-opioid pain biotech SiteOne for up to $1BEli Lilly is deepening its presence in the non-opioid pain field by buying California biotech SiteOne T… [+111 chars]...
Read moreLONDON,ENGLAND - MAY 30: A photo illustration of a Mounjaro pen on May 30 2025 in London, England. ... More Mounjaro is a treatment for weight loss and type 2 diabetes. (Photo by Peter Dazeley via Ge… [+3749 chars]...
Read more